Company
Colossal Biosciences
Colossal Biosciences uses CRISPR and genetic engineering to de-extinct previously lost species, beginning with the woolly mammoth. The company aims to restore Earth's ecosystems and advance biotechnology applications in human health and nutrition. Founded by George Church and Ben Lamm, Colossal operates laboratories focused on genomics research and responsible biological innovation.
Colossal Biosciences is a privately held company operating in the biotech & pharma sector, based in USA. Leadership tracked by CEOInsider includes Ben Lamm (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage has focused on Colossal Biosciences' expansion of its de-extinction research program globally, with particular emphasis on leadership's vision for artificial intelligence applications beyond mammoth revival, including drug discovery and biological aging. Headlines have highlighted the company's partnerships, facility openings, and recent funding developments, while also featuring commentary from CEO Ben Lamm on the role of AI in advancing the company's scientific initiatives across multiple continents.
Summarized from the headlines in the sidebar; see each source for the full story.